Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Gelfand

Showing results (11-20 of 80) with videos related to

Pageof 8
Sort By:
Current Clinical Topics in Infectious Diseases|October 21, 1998
BabesiosisJ A Gelfand, M V Callahan
American Journal of Clinical Pathology|January 1, 1983
A study of optimal reaction conditions for an assay of the human alternative complement pathwayK A Joiner, A Hawiger, J A Gelfand
Journal of Immunological Methods|January 1, 1979
A sensitive microassay for the murine alternative complement pathwayK A Joiner, R Shahon, J A Gelfand
Immunological Communications|January 1, 1980
The effect of cobra venom factor on alternative pathway hemolytic activity in miceK A Joiner, A Hawiger, J A Gelfand
Immunologic Research|January 1, 1989
Interleukin-1 and the response to injuryE Kaplan, C A Dinarello, J A Gelfand
Blood|October 15, 1990
Recombinant C5a stimulates transcription rather than translation of interleukin-1 (IL-1) and tumor necrosis factor: translational signal provided by lipopolysaccharide or IL-1 itselfR Schindler, J A Gelfand, C A Dinarello
Progress in Clinical and Biological Research|January 1, 1989
Interleukin-1 induces a shock-like state in rabbits: synergism with tumor necrosis factor and the effect of ibuprofenC A Dinarello, S Okusawa, J A Gelfand
Infection and Immunity|October 1, 1981
Activation of the alternative complement pathway by blood culture isolates of Bacteroides fragilisK A Joiner, A Hawiger, J A Gelfand
Annals of Surgery|July 1, 1983
Preferential activation and depletion of the alternative complement pathway by burn injuryJ A Gelfand, M Donelan, J F Burke
Progress in Clinical and Biological Research|January 1, 1989
Interleukin-1 induces a shock-like state in rabbits: synergism with tumor necrosis factor and the effect of cyclooxygenase inhibitionC A Dinarello, S Okusawa, J A Gelfand
Pageof 8

Showing results (11-20 of 80) with videos related to

Sort By:
Pageof 8
Current Clinical Topics in Infectious Diseases|October 21, 1998
BabesiosisJ A Gelfand, M V Callahan
American Journal of Clinical Pathology|January 1, 1983
A study of optimal reaction conditions for an assay of the human alternative complement pathwayK A Joiner, A Hawiger, J A Gelfand
Journal of Immunological Methods|January 1, 1979
A sensitive microassay for the murine alternative complement pathwayK A Joiner, R Shahon, J A Gelfand
Immunological Communications|January 1, 1980
The effect of cobra venom factor on alternative pathway hemolytic activity in miceK A Joiner, A Hawiger, J A Gelfand
Immunologic Research|January 1, 1989
Interleukin-1 and the response to injuryE Kaplan, C A Dinarello, J A Gelfand
Blood|October 15, 1990
Recombinant C5a stimulates transcription rather than translation of interleukin-1 (IL-1) and tumor necrosis factor: translational signal provided by lipopolysaccharide or IL-1 itselfR Schindler, J A Gelfand, C A Dinarello
Progress in Clinical and Biological Research|January 1, 1989
Interleukin-1 induces a shock-like state in rabbits: synergism with tumor necrosis factor and the effect of ibuprofenC A Dinarello, S Okusawa, J A Gelfand
Infection and Immunity|October 1, 1981
Activation of the alternative complement pathway by blood culture isolates of Bacteroides fragilisK A Joiner, A Hawiger, J A Gelfand
Annals of Surgery|July 1, 1983
Preferential activation and depletion of the alternative complement pathway by burn injuryJ A Gelfand, M Donelan, J F Burke
Progress in Clinical and Biological Research|January 1, 1989
Interleukin-1 induces a shock-like state in rabbits: synergism with tumor necrosis factor and the effect of cyclooxygenase inhibitionC A Dinarello, S Okusawa, J A Gelfand
Pageof 8